High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.3M
$4,289,698
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-04-01
$466,619x3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-04-01 | $466,619x3 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-04
$390,825x3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-04 | $390,825x3 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$361,860x5
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $361,860x5 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-07
$1,455,613Largex4
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-07 | $1,455,613Largex4 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-04
$817,500
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-04 | $817,500 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-05
$593,903x4
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-05 | $593,903x4 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-01
$203,378
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-01 | $203,378 | S | Form 4 |